Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Asahi SongwonQ4 FY26Chemicals & Petrochemicals
Home/Stocks/Asahi Songwon/Q4 FY26

Asahi Songwon Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹370P/E: 12.4Market Cap: ₹434 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

No

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
- Blue standalone business is operating at ~80%-85% utilization with limited volume growth potential; focus will be on pricing growth and operational efficiencies to sustain and improve margins (Pages 31-32). - AZO pigment business revenue was Rs. 78 crores with PBT loss; expected to break even next year with utilization increasing from 65% to 75%-85%, supported by small CAPEX for capacity expansion (Pages 26-27, 19). - Atlas subsidiaries (API segment) revenue around Rs.150 crores, gross margin 30%-35%; EBITDA peak potential is high due to diverse product pricing; breakeven targeted in FY27-FY28 (Pages 33-36). - Group aims for steady, consistent volume and bottom-line growth across businesses, with targeted revenue growth towards Rs. 1000 crores over the next few years (Page 14). - Strategic moves including new senior hires in API marketing expected to enhance growth and market penetration (Page 26). Overall, revenue growth driven by improved pricing, increased utilization in AZO and API segments, and operational efficiencies.

Margin guidance

Category 3
  • →Consolidated EBITDA peak expected around Rs. 100 crores: Rs. 50-55 crores from standalone (Blue) business and Rs. 50 crores from subsidiaries (Page 36).
  • →Standalone Blue business aims for Rs. 400+ crores revenue with 13%-14% EBITDA margin (~Rs. 50-55 crores EBITDA) achievable by FY27 (Page 34).
  • →Atlas (subsidiary) business EBITDA margin targeted at 15%-16% over time with peak potential EBITDA ceiling high, though exact numbers are variable due to product price differences (Pages 33-34).
  • →AZO pigment business expects to move from ~65% to 75%-85% utilization in next 3-4 quarters, with small CAPEX (Rs. 10-15 crores) planned to expand capacity and improve margins (Pages 19-20, 12).
  • →Management targets sustained volume and EBITDA growth with operational efficiency improvements and pricing benefits over next few years (Pages 33, 6).
  • →Long-term goal to reach Rs. 1000 crores revenue supported by strategic initiatives and growth in subsidiaries (Page 13).

3 more insights locked — sign up free to unlock

Fundraise plans

  • →There is no mention of any planned new fundraising through debt or equity in the discussed transcript.
  • →The company has been focused on debt reduction, with interest costs declining (Rs. 3.30 crores in Q4 FY26, down 14.15% YoY).
  • →No CAPEX is planned for the standalone business; internal projects, not requiring large investments, are expected to boost capacity slightly.
  • →For subsidiaries (Chattral and Atlas), the company expects to achieve peak turnover without additional CAPEX.
  • →Some small CAPEX (~Rs. 10-15 crores) may be done to expand capacity by 1.5x, leveraging existing infrastructure, but no large fundraising is indicated.
  • →Management emphasizes improving operational efficiency and utilizing existing capacities to grow revenues and profitability.
  • →Overall, the focus appears to be on internal growth and debt reduction rather than raising new capital.

Order book

The transcript provided (pages 1 to 36) does not explicitly mention the current or expected order book or pending orders for Asahi Songwon Colors Limited. There is no direct information or data related to order books or pending orders discussed during the Q4FY26 conference call transcript. The discussion mainly revolves around capacity utilization, pricing, revenue, EBITDA, operational efficiencies, margins, and outlook for various segments like Blue business, AZO pigments, and API. If you would like, I can help analyze any other specific aspect mentioned or summarize the company's operational or financial outlook based on the transcript.

Capex plans

No
  • →No major new CAPEX is planned currently; focus is on utilizing existing capacities and improving operational efficiencies.
  • →Small internal projects and efficiency enhancements are ongoing to boost capacity without significant capital outlay.
  • →For the AZO business, a capacity expansion is contemplated once utilization hits 85%, involving a smaller CAPEX (around Rs. 10-15 crores) due to prior investments in infrastructure; this expansion could increase capacity to 1.5x.
  • →The two subsidiaries (Chattral and Atlas) are expected to reach Rs. 250-280 crores turnover at peak without any additional CAPEX.
  • →The company prefers internal efficiency projects and backward integration to improve capacity and margins rather than large-scale capital investments.
  • →The strategy focuses on achieving higher fixed asset turnover and volume growth using existing assets over the next 2-3 years.

How does Asahi Songwon rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Asahi Songwon
Rev 3Mar 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does Asahi Songwon rank in Chemicals & Petrochemicals?

Compare Asahi Songwon against every Chemicals & Petrochemicals company (Q4 FY26) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q4 FY26 earnings insight — Asahi Songwon

Other quarters — Asahi Songwon

Q4 FY25Q2 FY25Q4 FY24Q2 FY24Q4 FY23Q2 FY23Q4 FY22Q2 FY22Q4 FY21

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
Asahi Songwon full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Asahi Songwon's management said in earlier quarters

  • Q4 FY25 earnings call analysis →
  • Q4 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

  • Epigral (Q1 FY27)

    Profit after tax (PAT) grew 25% in Q1 FY27 compared to Q1 FY26, reflecting resilience despite a challenging environment. Key concall takeaways from Epigral's…

  • S H Kelkar & Company Ltd (Q1 FY27)

    15 crore). Key concall takeaways from S H Kelkar & Company Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF